©The Author(s) 2025.
World J Gastrointest Oncol. Oct 15, 2025; 17(10): 110415
Published online Oct 15, 2025. doi: 10.4251/wjgo.v17.i10.110415
Published online Oct 15, 2025. doi: 10.4251/wjgo.v17.i10.110415
Table 1 Cancer types and candidate risk factors
| Cancer type | Candidate risk factors | Ref. |
| Intrahepatic cholangiocarcinoma | Liver fluke infection (Opisthorchis, Clonorchis); chronic liver disease (HBV, HCV, cirrhosis); PSC; hepatolithiasis; exposure to thorotrast or chemicals | [4,5] |
| Gallbladder cancer | Gallstones; large gallbladder polyps (> 10 mm); porcelain gallbladder; PBM; chronic Salmonella infection | [4,6-9,11] |
| Extrahepatic cholangiocarcinoma | PSC; PBM; liver fluke infection; chronic biliary inflammation or strictures | [4,5,10,11] |
| Ampullary cancer | FAP; Lynch syndrome; PBM | [4,11] |
- Citation: Nakagawa K, Tsujinaka S, Katayose Y, Yambe K, Sakurai H, Takami K, Kondo N, Yamamoto K, Shibata C. Current insights and future perspectives of treatment strategies for biliary tract cancer. World J Gastrointest Oncol 2025; 17(10): 110415
- URL: https://www.wjgnet.com/1948-5204/full/v17/i10/110415.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i10.110415